Human papillomavirus (HPV) is closely related to the development of cervical cancer. The role of HPV vaccine in the prevention and treatment of cervical diseases caused by HPV infection is gradually taken into account. This review summarizes the recent research progress of preventive and therapeutic HPV vaccines in the prevention and treatment of cervical cancer. Quadrivalent HPV (HPV6/11/16/18) vaccine Gardasil, bivalent HPV (HPV16/18) vaccine Cervarix, and a new nine-valent HPV (HPV6/11/16/18/31/33/45/52/58) vaccine Gardasil 9 have been listed and applied in clinic among the preventive vaccines. However, therapeutic HPV vaccines are still in the research stage and more experiments are needed to improve the immunogenicity and safety for clinical trials in humankind.%高危型人乳头瘤病毒(human papillomavirus, HPV)感染与宫颈癌的发生、发展关系密切。HPV疫苗在HPV感染所致宫颈疾病防治中的作用逐渐受到重视。本文介绍宫颈癌防治用预防性和治疗性HPV疫苗的研究进展。预防性HPV疫苗中的四价HPV(HPV6/11/16/18)疫苗Gardasil、二价HPV(HPV16/18)疫苗Cervarix和九价HPV (HPV6/11/16/18/31/33/45/52/58)疫苗Gardasil 9已获准上市并用于临床。治疗性HPV疫苗均尚处于研究阶段,且免疫原性与安全性仍有待提高。
展开▼